EUVIMEDEUVIMED entdecken
Crossref

Dual Oxygen‐Supply Immunosuppression‐Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid‐Derived Suppressor Cells

Zhengyang Yang iD, Huaqin Zuo, Yuchen Hou, Shuqin Zhou, Ying Zhang, Wanren Yang, Jian He, Xiaofei Shen, Qing Peng

Small · 2024

DOI: 10.1002/smll.202406860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Zhengyang Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's …. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Nanomedicine, Oxygen, Tumor Microenvironment. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Science and Technology Program of Guangzhou, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid‐derived suppressor cells (MDSCs) are reported to be responsible for the negative prognosis of colorectal cancer (CRC) patients due to the mediated immunosuppressive tumor microenvironment (TME). The selective and chronic circumvention of tumor‐infiltrated MDSCs has potential clinical significance for CRC treatment, which unluckily remains a technical challenge. Because tumor hypoxia makes a significant contribution to the recruitment of MDSCs in tumor sites, a dual oxygen‐supplied immunosuppression‐inhibiting nanomedicine (DOIN) is demonstrated for overcoming tumor hypoxia, which achieves selective and long‐term inhibition of intratumoral recruitment of MDSCs. The DOIN is constructed by the encasement of perfluorooctyl bromide (PFOB) and 4‐methylumbelliferone (4‐MU) into a TME‐responsive amphiphilic polymer. This nanoplatform directly carries oxygen to the tumor region and simultaneously loosens the condensed tumor extracellular matrix for the normalization of tumor vasculature, which selectively remodels the TME toward one adverse to the intratumoral recruitment of MDSCs. Importantly, this nanoplatform offers a long‐acting alleviation of the hypoxic TME, chronically avoiding the comeback of tumor‐infiltrated MDSCs. Consequently, the immunosuppressive TME is relieved, and T cells are successfully proliferated and activated into cytotoxic T lymphocytes, which boosts a systemic immune response and contributes to lasting inhibition of tumor growth with a prolonged survival span of xenograft.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsNanomedicineOxygenTumor MicroenvironmentAnimalsHumansCell Line, TumorImmunosuppression TherapyFluorocarbonsMiceHydrocarbons, Brominated

Stichwörter der Autor:innen

colorectal cancerenhanced immunoreactivityhypoxic tumor microenvironmentmyeloid‐derived suppressor cellsnanoplatform

Substanzen

OxygenFluorocarbonsperflubronHydrocarbons, Brominated

Autor:innen und Institutionen

  • Central Laboratory of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.
  • Department of Hepatobiliary Surgery II, General Surgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510000, China.
  • Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Beiji…
  • Department of Hematology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China.
  • Department of General Surgery, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230021, China.
  • Department of Anesthesiology of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, China.

ORCID-Profile: Zhengyang Yang

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Science and Technology Program of Guangzhou
  • National Natural Science Foundation of China

Zitieren

APA

Yang, Z., Zuo, H., Hou, Y., Zhou, S., Zhang, Y., Yang, W., He, J., Shen, X., & Peng, Q. (2024). Dual Oxygen‐Supply Immunosuppression‐Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid‐Derived Suppressor Cells. Small. https://doi.org/10.1002/smll.202406860

Vancouver

Yang Z, Zuo H, Hou Y, Zhou S, Zhang Y, Yang W, et al. Dual Oxygen‐Supply Immunosuppression‐Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid‐Derived Suppressor Cells. Small. 2024. doi:10.1002/smll.202406860

BibTeX
@article{Yang2024,
  author = {Yang, Zhengyang and Zuo, Huaqin and Hou, Yuchen and Zhou, Shuqin and Zhang, Ying and Yang, Wanren and He, Jian and Shen, Xiaofei and Peng, Qing},
  title = {Dual Oxygen‐Supply Immunosuppression‐Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid‐Derived Suppressor Cells},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202406860}
}
Kostenlos starten →